Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production

J Biol Chem. 1999 May 28;274(22):15875-82. doi: 10.1074/jbc.274.22.15875.

Abstract

We previously reported that several stresses can induce cytokine-induced neutrophil chemoattractant expression in a nuclear factor kappaB (NF-kappaB)-dependent manner. In this study, we focused further on the regulation of NF-kappaB. The activation of NF-kappaB and the subsequent cytokine-induced neutrophil chemoattractant induction in response to interleukin-1beta (IL-1beta) were inhibited by proteasome inhibitors, MG132 and proteasome inhibitor I. Translocation of NF-kappaB into nuclei occurs by the phosphorylation, multi-ubiquitination, and degradation of IkappaBalpha, a regulatory protein of NF-kappaB. Nascent IkappaBalpha began to degrade 5 min after treatment with IL-1beta and disappeared completely after 15 min. However, IkappaBalpha returned to basal levels after 45-60 min. Interestingly, resynthesized IkappaBalpha was already phosphorylated at Ser-32. These results suggest that 1) the upstream signals are still activated, although the translocation of NF-kappaB peaks at 15 min; and 2) the regulated protein(s) acts downstream of IkappaBalpha phosphorylation. Western blotting showed that the resynthesized and phosphorylated IkappaB molecules were also upward-shifted by multi-ubiquitination in response to IL-1beta treatment. On the other hand, ATP-dependent Leu-Leu-Val-Tyr cleaving activity transiently increased, peaked at 15 min, and then decreased to basal levels at 60 min. Furthermore, the cytosolic fraction that was stimulated by IL-1beta for 15 min, but not for 0 and 60 min, could degrade phosphorylated and multi-ubiquitinated IkappaBalpha. These results indicate that the transient translocation of NF-kappaB in response to IL-1beta may be partly dependent on transient proteasome activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzoquinones
  • Chemokines, CXC*
  • Chemotactic Factors / genetics
  • Cysteine Endopeptidases / metabolism*
  • DNA-Binding Proteins / metabolism*
  • Enzyme Activation
  • Gene Expression Regulation / drug effects
  • Glioma
  • Growth Substances / genetics
  • I-kappa B Proteins*
  • Intercellular Signaling Peptides and Proteins*
  • Interleukin-1 / metabolism*
  • Lactams, Macrocyclic
  • Leupeptins / pharmacology
  • Multienzyme Complexes / metabolism*
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism*
  • Oligopeptides / metabolism
  • Phosphorylation
  • Protease Inhibitors / pharmacology
  • Proteasome Endopeptidase Complex
  • Quinones / pharmacology
  • RNA, Messenger / metabolism
  • Rats
  • Rifabutin / analogs & derivatives
  • Transcriptional Activation / drug effects
  • Tumor Cells, Cultured
  • Ubiquitins / metabolism*

Substances

  • Benzoquinones
  • Chemokines, CXC
  • Chemotactic Factors
  • DNA-Binding Proteins
  • Growth Substances
  • I-kappa B Proteins
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-1
  • Lactams, Macrocyclic
  • Leupeptins
  • Multienzyme Complexes
  • NF-kappa B
  • Nfkbia protein, rat
  • Oligopeptides
  • Protease Inhibitors
  • Quinones
  • RNA, Messenger
  • Ubiquitins
  • NF-KappaB Inhibitor alpha
  • Rifabutin
  • herbimycin
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde